IFNG and cancer: The increased expression of c-Myc, which is driven by IFN-γ through STAT-3-dependent signaling, has a crucial function in orchestrating a metabolic shift that not only supports tumor proliferation but also reduces the immunogenicity of the tumor, allowing the cancer to avoid detection by the immune system effectively in this model.